DiaMedica Therapeutics to Report First Quarter 2020 Financial Results and Provide a Business Update May 14, 2020
May 07 2020 - 4:30PM
Business Wire
DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that
its first quarter 2020 financial results will be released after the
markets close on Wednesday, May 13th. DiaMedica will host a live
conference call on Thursday, May 14th at 7:00 AM Central Time to
discuss its business update and financial results.
Conference Call details:
Date:
Thursday, May 14, 2020
Time:
7:00 AM CT / 8:00 AM ET
Web access:
https://event.on24.com/wcc/r/2158468/5BAA62D375A1F892573859D379BAF858
Dial In:
(833) 502-0492 (domestic)
(778) 560-2558 (international)
Conference ID:
8757888
Interested parties may access the conference call by dialing in
or listening to the simultaneous webcast. Listeners should log on
to the website or dial in 15 minutes prior to the call. The webcast
will remain available for play back on DiaMedica’s website, under
investor events and presentations, following the earnings call and
for 12 months thereafter. A telephonic replay of the conference
call will be available until May 21, 2020, by dialing (800)
585-8367 (US Toll Free), (416) 621-4642 (International), replay
passcode 8757888.
About DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc. is a clinical stage
biopharmaceutical company focused on developing novel treatments
for chronic kidney diseases and neurological disorders. DiaMedica’s
shares are listed on The Nasdaq Capital Market under the trading
symbol “DMAC.”
For more information, please visit www.diamedica.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200507005966/en/
Scott Kellen Chief Financial Officer Phone: (763) 496-5118
skellen@diamedica.com
DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
From Apr 2023 to Apr 2024